Skip to main content
. 2017 Mar 24;22(3):325–337. doi: 10.1177/2472630317700346

Figure 5.

Figure 5.

PharmaFlow automated platform overview. The PharmaFlow platform is automated and capable of measuring up to 2000 points per sample using the whole sample with its native environment. It can evaluate effects selectively in cancer cell subpopulations and analyze data with pharmacokinetic and pharmacodynamic population models that fit dose responses for all samples simultaneously, achieving high clinical correlation.